[1]
Li, Q. et al. 2024. Persistent COVID-19 Infection In A B-Cell Depleted Patient With Successful Viral Clearance After Tixagevimab-Cilgavimab. Archives of Clinical and Medical Case Reports. 8, 3 (Jun. 2024), 117–120.